No CrossRef data available.
Article contents
P03-319 - The Truth About Polypharmacy in Elderly Inpatient Population
Published online by Cambridge University Press: 17 April 2020
Abstract
Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction
There is increasing concern about the use of multiple medications in psychiatric patients.Older adults make up 15% of the population yet they account for 30% of the prescribed medications. There is increased risk of falls, confusion and consequent functional decline as a result of potential interactions and adverse drug events.
Aims/Objectives
To document the extent of polypharmacy and potential drug interactions in elderly inpatient population at the point of discharge.
Methods
25 consecutive discharge summaries from an elderly mixed (organic and functional) inpatient unit were evaluated.
Results
out of 25 (15 female and 10 male) patients with age range of 59-97 years, an average of 6.5 drugs (Range:2-17; Median:6) were prescribed. An average of 3.1 pair of interactions (Range:0-15; Median:3) were noted. Potentially hazardous interactions (Average 0.68; Range:0-4) was a worrying trend in this patient group.
Conclusions
Polypharmacy is commonplace in elderly patients and is worrisome. Different strategies like in-house pharmacist may offer some safeguards though further research is needed.
- Type
- Psychopharmacological treatment and biological therapies
- Information
- Copyright
- Copyright © European Psychiatric Association 2010
You have
Access
Comments
No Comments have been published for this article.